Boehringer Ingelheim, a Germany-based drugs company, has become a strategic partner of US-based digital health accelerator Rock Health.

Rock Health also has as corporate partners: Switzerland-based drugs group Roche’s Genentech biotech subsidiary; Alexandria Real Estate Equities, which owns biotech buildings; and public relations firm Ogilvy. Rock has 11 start-ups for its latest accelerator programme, including CRIXlabs, Apapsis and Cancer IQ – get the full list of companies from GigaOm‘s article.

And Johnson & Johnson (J&J) marked the official opening of its new…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?